Evidence map›Paper›PMID 31359336›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2020

Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM.

R Vera, E González-Flores, C Rubio, J Urbano, M Valero Camps, J J Ciampi-Dopazo, J Orcajo Rincón, V Morillo Macías, M A Gomez Braco, G Suarez-Artacho

Abstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  19. Article
  20. Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

R VeraMedical Oncology, Complejo Hospitalario de Navarra, Calle Irunlarrea, 3, 31008, Pamplona, Navarra, Spain. ruth.vera.garcia@cfnavarra.es.ORCID http://orcid.org/0000-0003-0156-0029
E González-FloresMedical Oncology, Hospital Virgen de Las Nieves, Granada, Spain.
C RubioRadiation Oncology Department, University Hospital HM Sanchinarro, Madrid, Spain.
J UrbanoVascular and Interventional Radiology, Vithas Hospitals Group, Madrid, Spain.
M Valero CampsNuclear Medicine, Clínica Rotger (Quiron Salud), Palma de Mallorca, Spain.
J J Ciampi-DopazoInterventional Radiology Unit, Complejo Hospitalario de Toledo, Toledo, Spain.
J Orcajo RincónNuclear Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
V Morillo MacíasRadiation Oncology, Hospital Provincial de Castellón, Castellón, Spain.
M A Gomez BracoHepatobiliary and Liver Transplantation Unit, University Hospital Virgen del Rocío, Sevilla, Spain.
G Suarez-ArtachoHepatobiliary and Liver Transplantation Unit, University Hospital Virgen del Rocío, Sevilla, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% of patients with CRC will have metastases at the time of diagnosis, and more than 50% of patients with CRC develop metastatic disease during the course of their disease. A group of experts from the Spanish Society of Medical Oncology, the Spanish Association of Surgeons, the Spanish Society of Radiation Oncology, the Spanish Society of Vascular and Interventional Radiology, and the Spanish Society of Nuclear Medicine and Molecular Imaging met to discuss and provide a multidisciplinary consensus on the management of liver metastases in patients with CRC. The group defined the different scenarios in which the disease can present: fit or unfit patients with resectable liver metastases, patients with potential resectable liver metastases, and patients with unresectable liver metastases. Within each scenario, the different strategies and therapeutic approaches are discussed.

Indexed as

AlgorithmsColorectal NeoplasmsCombined Modality TherapyHepatectomyHumansLiver NeoplasmsMedical OncologyPatient Care TeamSpainChemotherapyColorectal cancerConsensusLiver metastasesLocoregional therapiesSurgery

Identifiers

PMID31359336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.